Nasdaq · Common stock
Aktis Oncology (AKTS)
$15.73 $0.00 (0.00%)
- Day’s range
- $15.60–$16.14
- Volume
- 149,998
AKTS price history
AKTS closed at $15.73 on Oct. 26, 2026. Over the past year, its daily close ranged from $15.06 on Oct. 16, 2026 to $32.23 on June 30, 2026.
Data table: AKTS daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $15.73 |
| Oct. 23, 2026 | $15.73 |
| Oct. 22, 2026 | $16.76 |
| Oct. 21, 2026 | $16.42 |
| Oct. 20, 2026 | $16.08 |
| Oct. 19, 2026 | $15.11 |
| Oct. 16, 2026 | $15.06 |
| Oct. 15, 2026 | $16.01 |
| Oct. 14, 2026 | $16.49 |
| Oct. 13, 2026 | $16.64 |
| Oct. 12, 2026 | $17.34 |
| Oct. 9, 2026 | $18.15 |
| Oct. 8, 2026 | $17.74 |
| Oct. 7, 2026 | $18.00 |
| Oct. 6, 2026 | $17.86 |
| Oct. 5, 2026 | $18.52 |
| Oct. 2, 2026 | $18.52 |
| Oct. 1, 2026 | $18.52 |
| Sept. 30, 2026 | $19.47 |
| Sept. 29, 2026 | $19.69 |
| Sept. 28, 2026 | $19.35 |
| Sept. 25, 2026 | $19.43 |
| Sept. 24, 2026 | $19.63 |
| Sept. 23, 2026 | $19.72 |
| Sept. 22, 2026 | $22.11 |
| Sept. 21, 2026 | $21.43 |
| Sept. 18, 2026 | $21.88 |
| Sept. 17, 2026 | $22.86 |
| Sept. 16, 2026 | $22.71 |
| Sept. 15, 2026 | $22.41 |
| Sept. 14, 2026 | $23.17 |
| Sept. 11, 2026 | $23.30 |
| Sept. 10, 2026 | $23.94 |
| Sept. 9, 2026 | $24.06 |
| Sept. 8, 2026 | $25.02 |
| Sept. 4, 2026 | $27.05 |
| Sept. 3, 2026 | $26.65 |
| Sept. 2, 2026 | $26.92 |
| Sept. 1, 2026 | $25.99 |
| Aug. 31, 2026 | $25.91 |
| Aug. 28, 2026 | $25.78 |
| Aug. 27, 2026 | $26.18 |
| Aug. 26, 2026 | $26.51 |
| Aug. 25, 2026 | $26.69 |
| Aug. 24, 2026 | $25.98 |
| Aug. 21, 2026 | $24.07 |
| Aug. 20, 2026 | $24.00 |
| Aug. 19, 2026 | $25.02 |
| Aug. 18, 2026 | $25.00 |
| Aug. 17, 2026 | $24.72 |
| Aug. 14, 2026 | $24.93 |
| Aug. 13, 2026 | $23.79 |
| Aug. 12, 2026 | $24.00 |
| Aug. 11, 2026 | $24.77 |
| Aug. 10, 2026 | $24.10 |
| Aug. 7, 2026 | $24.13 |
| Aug. 6, 2026 | $23.44 |
| Aug. 5, 2026 | $22.65 |
| Aug. 4, 2026 | $22.84 |
| Aug. 3, 2026 | $22.23 |
| July 31, 2026 | $22.07 |
| July 30, 2026 | $23.00 |
| July 29, 2026 | $22.39 |
| July 28, 2026 | $22.97 |
| July 27, 2026 | $24.21 |
| July 24, 2026 | $23.89 |
| July 23, 2026 | $24.01 |
| July 22, 2026 | $24.81 |
| July 21, 2026 | $24.63 |
| July 20, 2026 | $23.96 |
| July 17, 2026 | $24.89 |
| July 16, 2026 | $25.02 |
| July 15, 2026 | $26.00 |
| July 14, 2026 | $25.18 |
| July 13, 2026 | $25.58 |
| July 10, 2026 | $27.88 |
| July 9, 2026 | $28.42 |
| July 8, 2026 | $28.69 |
| July 7, 2026 | $27.58 |
| July 6, 2026 | $26.56 |
| July 2, 2026 | $31.76 |
| July 1, 2026 | $30.89 |
| June 30, 2026 | $32.23 |
| June 29, 2026 | $30.11 |
| June 26, 2026 | $29.44 |
| June 25, 2026 | $31.15 |
| June 24, 2026 | $28.70 |
| June 23, 2026 | $27.01 |
| June 22, 2026 | $24.79 |
| June 18, 2026 | $24.09 |
| June 17, 2026 | $23.53 |
| June 16, 2026 | $22.63 |
| June 15, 2026 | $20.69 |
| June 12, 2026 | $21.93 |
| June 11, 2026 | $19.46 |
| June 10, 2026 | $18.58 |
| June 9, 2026 | $18.98 |
| June 8, 2026 | $18.97 |
| June 5, 2026 | $18.87 |
| June 4, 2026 | $19.89 |
| June 3, 2026 | $19.37 |
| June 2, 2026 | $20.26 |
| June 1, 2026 | $19.48 |
| May 29, 2026 | $20.74 |
| May 28, 2026 | $20.43 |
| May 27, 2026 | $19.92 |
| May 26, 2026 | $20.58 |
| May 22, 2026 | $20.34 |
| May 21, 2026 | $19.12 |
| May 20, 2026 | $19.03 |
| May 19, 2026 | $18.50 |
| May 18, 2026 | $18.61 |
| May 15, 2026 | $19.55 |
| May 14, 2026 | $19.50 |
| May 13, 2026 | $19.53 |
| May 12, 2026 | $19.73 |
| May 11, 2026 | $18.27 |
| May 8, 2026 | $18.60 |
| May 7, 2026 | $18.84 |
| May 6, 2026 | $20.03 |
| May 5, 2026 | $19.44 |
| May 4, 2026 | $19.00 |
| May 1, 2026 | $19.42 |
| April 30, 2026 | $18.75 |
| April 29, 2026 | $18.72 |
| April 28, 2026 | $18.60 |
| April 27, 2026 | $20.09 |
| April 24, 2026 | $21.26 |
| April 23, 2026 | $22.08 |
| April 22, 2026 | $22.00 |
| April 21, 2026 | $20.50 |
| April 20, 2026 | $20.83 |
| April 17, 2026 | $20.25 |
| April 16, 2026 | $18.60 |
| April 15, 2026 | $18.09 |
| April 14, 2026 | $17.84 |
| April 13, 2026 | $17.34 |
| April 10, 2026 | $16.88 |
| April 9, 2026 | $17.67 |
| April 8, 2026 | $16.98 |
| April 7, 2026 | $16.72 |
| April 6, 2026 | $16.37 |
| April 2, 2026 | $17.37 |
| April 1, 2026 | $17.07 |
| March 31, 2026 | $17.89 |
| March 30, 2026 | $16.54 |
| March 27, 2026 | $15.19 |
| March 26, 2026 | $17.62 |
| March 25, 2026 | $18.64 |
| March 24, 2026 | $18.63 |
| March 23, 2026 | $18.18 |
| March 20, 2026 | $17.70 |
| March 19, 2026 | $17.98 |
| March 18, 2026 | $18.28 |
| March 17, 2026 | $19.23 |
| March 16, 2026 | $19.77 |
| March 13, 2026 | $18.99 |
| March 12, 2026 | $18.29 |
| March 11, 2026 | $19.41 |
| March 10, 2026 | $18.98 |
| March 9, 2026 | $19.06 |
| March 6, 2026 | $18.81 |
| March 5, 2026 | $20.54 |
| March 4, 2026 | $20.85 |
| March 3, 2026 | $20.22 |
| March 2, 2026 | $20.00 |
| Feb. 27, 2026 | $20.13 |
| Feb. 26, 2026 | $19.63 |
| Feb. 25, 2026 | $19.50 |
| Feb. 24, 2026 | $20.00 |
| Feb. 23, 2026 | $19.43 |
| Feb. 20, 2026 | $18.90 |
| Feb. 19, 2026 | $18.41 |
| Feb. 18, 2026 | $17.63 |
| Feb. 17, 2026 | $17.95 |
| Feb. 13, 2026 | $17.76 |
| Feb. 12, 2026 | $17.90 |
| Feb. 11, 2026 | $18.06 |
| Feb. 10, 2026 | $17.80 |
| Feb. 9, 2026 | $19.00 |
| Feb. 6, 2026 | $18.98 |
| Feb. 5, 2026 | $19.57 |
| Feb. 4, 2026 | $19.92 |
| Feb. 3, 2026 | $20.90 |
| Feb. 2, 2026 | $21.98 |
| Jan. 30, 2026 | $20.25 |
| Jan. 29, 2026 | $19.64 |
| Jan. 28, 2026 | $20.50 |
| Jan. 27, 2026 | $21.22 |
| Jan. 26, 2026 | $21.62 |
| Jan. 23, 2026 | $21.65 |
| Jan. 22, 2026 | $22.40 |
| Jan. 21, 2026 | $20.40 |
| Jan. 20, 2026 | $18.77 |
| Jan. 16, 2026 | $19.75 |
| Jan. 15, 2026 | $20.56 |
| Jan. 14, 2026 | $20.81 |
| Jan. 13, 2026 | $21.35 |
| Jan. 12, 2026 | $21.75 |
| Jan. 9, 2026 | $22.40 |
Key figures
- Average daily volume
- 365,746Past 3 months
- Market value
- $874.9M
- Dividend yield
- —
Price change
- 1 month
- −19.04%
- 3 months
- −34.16%
What Wall Street says about AKTS
In the past 90 days, Wall Street firms published 4 rating or price-target actions on AKTS: 3 new ratings and 1 reiterated rating.
| Action | Rating | |||
|---|---|---|---|---|
| Wedbush | Reiterates | Outperform | $35 | |
| Oppenheimer | Initiates coverage | Outperform | $40 | |
| BMO Capital | Initiates coverage | Outperform | $37 | |
| Wedbush | Initiates coverage | Outperform | $35 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Aktis Oncology, Inc. Common stock
Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. The company has one operating and reportable segment focused on the research and development of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. The company generates revenue from Collaboration agreement.
- Headquarters
- Boston, Mass.
- Employees
- 79
- Listed
- Jan. 9, 2026
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about AKTS is on the site yet.